← Eichor
Condition: Prenatal Exposure Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prenatal Exposure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
NA · 1 location(s) · University Hospital, Rouen · NCT03371641Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT06379971Maternal And Infant Antipsychotic Study
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06049953CARRII Native Intervention Optimization Trial
NA · 1 location(s) · University of Virginia · NCT07547696Scottish Advanced Fetal Research Study
Phase N/A · 1 location(s) · University of Aberdeen · NCT04613583Prenatal Music Exposure to Enhance Postnatal Language Development
NA · 2 location(s) · Chinese University of Hong Kong · NCT07699536A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteri
Phase N/A · 1 location(s) · Ascendis Pharma A/S · NCT07345494A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During P
Phase N/A · 4 location(s) · BioMarin Pharmaceutical · NCT05579548RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
Phase 2 · 1 location(s) · Wayne State University · NCT04395196A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Phase N/A · 1 location(s) · Phathom Pharmaceuticals, Inc. · NCT06660342Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06653660Pilot Study of Prenatal Choline Supplementation
Phase 2 · 1 location(s) · Wayne State University · NCT07699393A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Expo
NA · 1 location(s) · Hebrew University of Jerusalem · NCT07003282The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Phase N/A · 1 location(s) · The Task Force for Global Health · NCT05368974Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study
NA · 1 location(s) · Boston University · NCT05486793Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxoli
Phase N/A · 1 location(s) · Incyte Corporation · NCT06259669Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
NA · 1 location(s) · University of California, Los Angeles · NCT06847165Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
NA · 3 location(s) · IDeA States Pediatric Clinical Trials Network · NCT06423664A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod Dur
Phase N/A · 4 location(s) · argenx · NCT06299748Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Phase N/A · 1 location(s) · Pfizer · NCT05046613In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
Phase N/A · 1 location(s) · Columbia University · NCT07296107PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
Phase N/A · 4 location(s) · University of Colorado, Denver · NCT06141434
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.